111 related articles for article (PubMed ID: 16615519)
1. [Human cytomegalovirus in hematopoietic stem cell transplantation].
Mori T
Nihon Rinsho; 2006 Mar; 64 Suppl 3():480-4. PubMed ID: 16615519
[No Abstract] [Full Text] [Related]
2. [Diagnosis, treatment, and prophylaxis for cytomegalovirus disease following allogeneic stem cell transplantation].
Gondo H
Rinsho Ketsueki; 2003 Dec; 44(12):1154-60. PubMed ID: 14978931
[No Abstract] [Full Text] [Related]
3. Cytomegalovirus infection following stem cell transplantation.
Einsele H; Hebart H
Haematologica; 1999 Jun; 84 Suppl EHA-4():46-9. PubMed ID: 10907466
[No Abstract] [Full Text] [Related]
4. Comparison of antigenemia assay and semiquantitative polymerase chain reaction test for monitoring active cytomegalovirus infection in allogeneic hematopoietic cell transplant recipients.
Pajand O; Ziyaeyan M; Mousavi S; Fatolahzadeh B; Hojabri Z; Bahador A; Abdossamadi Z
Exp Clin Transplant; 2008 Jun; 6(2):149-54. PubMed ID: 18816243
[TBL] [Abstract][Full Text] [Related]
5. [Laboratory diagnosis of cytomegalovirus infections and disease].
Yoshida A
Rinsho Byori; 2008 Nov; 56(11):1034-42. PubMed ID: 19086460
[TBL] [Abstract][Full Text] [Related]
6. [Monitoring of CMV infection after bone marrow transplantation].
Okada M; Takemoto Y
Nihon Rinsho; 1998 Jan; 56(1):189-92. PubMed ID: 9465688
[TBL] [Abstract][Full Text] [Related]
7. [Impact of initial cytomegalovirus viral load on efficacy of preemptive therapy with ganciclovir in allogeneic stem cell transplant recipients].
Torre-Cisneros J; Caston-Osorio JJ; Martín C; Rivero A; Doblas A; Rojas R; Gómez P; Martínez F; Torres A
Enferm Infecc Microbiol Clin; 2010 Jan; 28(1):6-12. PubMed ID: 19409666
[TBL] [Abstract][Full Text] [Related]
8. [Therapy for cytomegalovirus infection].
Kitajima N
Nihon Rinsho; 2006 Mar; 64 Suppl 3():500-3. PubMed ID: 16615523
[No Abstract] [Full Text] [Related]
9. Saliva as a source of HCMV DNA in allogeneic stem cell transplantation patients.
Correia-Silva JF; Bruna-Romero O; Resende RG; Miranda LP; Oliveira FE; Costa FO; Xavier SG; Figueiredo-Neves SP; Almeida HC; Bittencourt H; Gomez RS
Oral Dis; 2010 Mar; 16(2):210-6. PubMed ID: 20374507
[TBL] [Abstract][Full Text] [Related]
10. Direct and indirect effects of cytomegalovirus: can we prevent them?
Razonable R
Enferm Infecc Microbiol Clin; 2010 Jan; 28(1):1-5. PubMed ID: 20022410
[No Abstract] [Full Text] [Related]
11. Monitoring of cytomegalovirus reactivation after allogeneic stem cell transplantation: comparison of an antigenemia assay and quantitative real-time polymerase chain reaction.
Yakushiji K; Gondo H; Kamezaki K; Shigematsu K; Hayashi S; Kuroiwa M; Taniguchi S; Ohno Y; Takase K; Numata A; Aoki K; Kato K; Nagafuji K; Shimoda K; Okamura T; Kinukawa N; Kasuga N; Sata M; Harada M
Bone Marrow Transplant; 2002 Apr; 29(7):599-606. PubMed ID: 11979310
[TBL] [Abstract][Full Text] [Related]
12. [Cytomegalovirus].
Maeda A; Fujieda M; Sato T; Wakiguchi H
Nihon Rinsho; 2010 Jun; 68 Suppl 6():314-8. PubMed ID: 20942067
[No Abstract] [Full Text] [Related]
13. Role of quantitative human cytomegalovirus PCR in predicting antiviral treatment response among high-risk hematopoietic stem-cell transplant recipients.
Safdar A; Bruorton M; Henslee-Downey JP; van Rhee F
Bone Marrow Transplant; 2004 Feb; 33(4):463-4. PubMed ID: 14716349
[No Abstract] [Full Text] [Related]
14. Risk for cytomegalovirus disease in patients receiving polymerase chain reaction-based preemptive antiviral therapy after allogeneic stem cell transplantation depends on transplantation modality.
Hebart H; Brugger W; Grigoleit U; Gscheidle B; Loeffler J; Schäfer H; Kanz L; Einsele H; Sinzger C
Blood; 2001 Apr; 97(7):2183-5. PubMed ID: 11286223
[No Abstract] [Full Text] [Related]
15. Surveillance of cytomegalovirus (CMV) DNAemia in pediatric allogeneic stem cell transplantation: incidence and outcome of CMV infection and disease.
Bordon V; Bravo S; Van Renterghem L; de Moerloose B; Benoit Y; Laureys G; Dhooge C
Transpl Infect Dis; 2008 Feb; 10(1):19-23. PubMed ID: 17511814
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of oral ganciclovir in prevention of cytomegalovirus infection in post-kidney transplant patients.
Ahsan N; Holman MJ; Yang HC
Clin Transplant; 1997 Dec; 11(6):633-9. PubMed ID: 9408699
[TBL] [Abstract][Full Text] [Related]
17. Use of a semi-quantitative PCR for cytomegalovirus DNA as a basis for pre-emptive antiviral therapy in allogeneic bone marrow transplant patients.
Ljungman P; Loré K; Aschan J; Klaesson S; Lewensohn-Fuchs I; Lönnqvist B; Ringdén O; Winiarski J; Ehrnst A
Bone Marrow Transplant; 1996 Apr; 17(4):583-7. PubMed ID: 8722359
[TBL] [Abstract][Full Text] [Related]
18. Cytomegalovirus pneumonia: presentation, diagnosis, and treatment.
Ljungman P
Semin Respir Infect; 1995 Dec; 10(4):209-15. PubMed ID: 8668848
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the COBAS Amplicor HCMV Monitor for early detection and monitoring of human cytomegalovirus infection after allogeneic stem cell transplantation.
Lengerke C; Ljubicic T; Meisner C; Loeffler J; Sinzger C; Einsele H; Hebart H
Bone Marrow Transplant; 2006 Jul; 38(1):53-60. PubMed ID: 16788683
[TBL] [Abstract][Full Text] [Related]
20. Cytomegalovirus antigenemia as a marker for antiviral therapy after heart transplantation.
Iberer F; Tscheliessnigg K; Halwachs G; Auer T; Wasler A; Petutschnigg B; Schreier G; Müller H; Allmayr T; Prenner G; Hipmair G; Grasser B; Freigassner M
J Heart Lung Transplant; 1996 Mar; 15(3):314-5. PubMed ID: 8777216
[No Abstract] [Full Text] [Related]
[Next] [New Search]
